Medical device software accounted for 61 percent of all designated innovative medical devices through last month.The Ministry of Food and Drug Safety said it is exploring ways for innovative medical devices to enjoy advantages in public tenders.The ministry said Friday that it has designated 13 prod

https://www.koreabiomed.com/news/articleView.html?idxno=21772

#koreabiomed

A panel of experts in pathology emphasized the need to improve institutional support to address reimbursement issues, data storage, and sharing of pathological-related data in hospitals so that digital pathology can be widely implemented.The Korean Society of Pathology (KSP) and the Korea Medical De

https://www.koreabiomed.com/news/articleView.html?idxno=21633

#koreabiomed

CG Invites said Friday that its stocks have been relisted on the Kosdaq market with the changed name from Crystal Genomics to CG Invites.At an extraordinary shareholder meeting in June, Crystal Genomics changed its name to CG Invites due to a change in its largest shareholder to New Lake Invites Inv

https://www.koreabiomed.com/news/articleView.html?idxno=21771

#koreabiomed

A survey shows that an information gap on Covid-19 vaccines is emerging between infectious disease specialists and general practitioners who directly administer vaccines to patients.The Korean Association of Medical Journalists (KAM) released the "Public and Expert Perception Survey on Covid-19 Vacc

https://www.koreabiomed.com/news/articleView.html?idxno=22025

#koreabiomed

More than one million Koreans are living with cancers as survival rates have improved thanks to the development of early detection, surgical treatment, and a variety of effective cancer therapies.While the cancer treatment has improved, a St. Mary's Seoul Hospital team, led by Professors Jung Mi-hya

https://www.koreabiomed.com/news/articleView.html?idxno=21803

#koreabiomed

GC Biopharma said Monday that its immunoglobulin blood product Alyglo (GC5107B, 10-percent intravenous immunoglobulin) has passed the U.S. Food and Drug Administration's preliminary review for marketing authorization.The company added that the U.S. FDA has also initiated the review of GC5107B for fi

https://www.koreabiomed.com/news/articleView.html?idxno=21729

#koreabiomed

Medical residents' applications for essential care departments, including pediatrics, continued to remain low in the second-half year, triggering calls for the government's active support to the 'unpopular but vital' sector.According to Rep. Lee Jong-seong of the ruling People Power Party, only four

https://www.koreabiomed.com/news/articleView.html?idxno=21870

#koreabiomed

MSD Korea said on Tuesday it has appointed Albert Kim, a former vice president of Samsung Bioepis, as the new managing director, effective August 1, 2023.The position has been vacant for six months after the previous managing director, Kevin Peters, left to serve as managing director at MSD Germany

https://www.koreabiomed.com/news/articleView.html?idxno=21681

#koreabiomed

Korea United Pharm said it has signed a five-year supply and distribution agreement with MCQ, a Thai-based pharmaceutical company specializing in drug distribution, for Levotics CR Tab., a mucoactive drug.Levotics CR Tab. is an incrementally modified drug (IMD) that improves compliance and convenien

https://www.koreabiomed.com/news/articleView.html?idxno=22024

#koreabiomed